DEERFIELD, Ill.--(BUSINESS WIRE)--Sterigenics International LLC, the leading global provider of outsourced contract sterilization services and a portfolio company of GTCR, today announced it has completed its $826 million acquisition of Nordion Inc. (TSX:NDN) (NYSE:NDZ).
“We are incredibly excited to welcome the Nordion employees to the global Sterigenics team,” said Michael Mulhern, Sterigenics International LLC CEO. “For more than 30 years, we have known the Nordion organization and have deep respect and appreciation for their people and expertise. By completing this acquisition, we are creating the only vertically integrated sterilization company in the world and will have a broader product portfolio, service offering, and global footprint to better serve customers worldwide. Moving forward, Sterigenics is extremely well positioned to build on its mission of improving global public health.”
As a standalone business within Sterigenics, Nordion will remain headquartered in Ottawa, Canada, and will continue to operate under the Nordion name.
Headquartered in Deerfield, Illinois, Sterigenics International LLC operates out of 39 facilities in 11 countries across the Americas, Europe and Asia and is a global leader in outsourced contract sterilization services, primarily to the medical device, pharmaceutical, food safety and high performance/specialty materials industries. As a result of its global service capabilities, and the proprietary Sterigenics GPS® platform that allows real time order tracking and just in time supply chain operation, it counts numerous Fortune 500 companies as clients, with relationships exceeding two decades.
Kirkland & Ellis LLP, Gowling Lafleur Henderson LLP and Cleary Gottlieb Steen & Hamilton LLP served as legal advisors, and Goldman, Sachs & Co. served as financial advisor to Sterigenics. This is the second strategic acquisition by Sterigenics this year. In March, Sterigenics closed the acquisition of Food Technology Service, Inc. a Mulberry, Florida irradiation facility that uses gamma radiation to provide contract sterilization services to the medical products, packaging and food industries.
About GTCR
Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare and Information Services & Technology industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $10 billion in over 200 companies. For more information, please visit www.gtcr.com.